Costochondritis — a benign condition that causes inflammation of the cartilage connecting your ribs to your breastbone. Also ...
Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
A source tells Bloomberg that Stephane Bancel will step down as the company’s Chief Commercial Officer, but retain the role of ...
Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.
Hosted on MSN1d
Moderna’s mRESVIA vaccine gains Health Canada approvalModerna CEO Stéphane Bancel said: "Today's approval is an example of how our mRNA platform can help address significant ...
CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
The vaccine maker reported a surprise profit and higher revenue than expected. CEO Stéphane Bancel said the company is ahead ...
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter. He will remain chief executive officer of the biotech company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback